Sorrento completes a roundtrip


Recent IPO Sorrento Therapeutics (SRNE -17.1%) trades close to its October 25 first day close of $8.62 representing almost a 50% drop from its March 21 peak of $16.40 as investors continue their exodus from the biotech sector.

iShares NASDAQ Biotech ETF (IBB -0.1%) is down 18% from its February 25 high of $275.40.

Perhaps Aegis Capital should revisit its $40 PT?

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs